SANARA MEDTECH INC
SANARA MEDTECH INC logo
SMTI

SANARA MEDTECH INC (SMTI)

$361.93%

Market is closed
– opens on 8 PM, 07 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$35.75
Day's Range
$36.4999
$17.41
52-Week Range
$39.99
1 month return10.94%
3 month return14.29%
1 year return30.58%
5 year return4.61%

Company Information

With a focus on improving patient outcomes through evidence-based healing solutions and services, Sanara MedTech Inc. markets and distributes wound and skin care products and is seeking to offer wound care and dermatology virtual consultation services via telemedicine to physicians, hospitals, clinics, and all post-acute care settings. Sanara's products are primarily sold in the North American advanced wound care and surgical tissue repair markets. Sanara MedTech markets and distributes CellerateRX® Surgical Activated Collagen® to the surgical markets as well as the following products to the wound care market: BIAKŌS™ Antimicrobial Skin and Wound Cleanser, BIAKŌS™ Antimicrobial Wound Gel, BIAKŌS™ Antimicrobial Skin and Wound Irrigation Solution, and HYCOL™ Hydrolyzed Collagen Powder and Gel. The company is constantly seeking long-term strategic partnerships with a focus on products and technologies that improve outcomes at a lower overall cost. In addition, Sanara is actively seeking to expand within its six focus areas of wound and skin care for the acute, post-acute, and surgical markets. The focus areas are debridement, biofilm removal, hydrolyzed collagen, advanced biologics, negative pressure wound therapy adjunct products, and the oxygen delivery system segment of the healthcare industry.
OrganizationSANARA MEDTECH INC
Employees63
CEOMr. Ronald T. Nixon
IndustryPharmaceuticals: Generic

Analyst Recommendation

based on 1 analysts ratings

Buy
100%
Buy
0%
Hold
0%
Sell

Based on 1 Wall street analysts offering stock ratings for SANARA MEDTECH INC(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 38.89%

Current

$36.0

Target

$50.0

Recommendation Trend

Based on 1 analyst

Current1M Ago3M Ago
Buy
1
6
6
Hold
0
1
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
293.3M
Book Value
$5.47
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-1.31
Wall Street Target Price
50.0

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
6.73
Enterprise Value
296.7M
Enterprise Value/Revenue
7.9
Enterprise Value/Ebitda
-26.02

Technicals

Beta
1.98
50 Day MA
31.8
200 Day MA
27.25

Institutional Holdings

Vanguard Group Inc

1.11%

EAM Investors, LLC

0.66%

Diametric Capital, LP

0.36%

Geode Capital Management, LLC

0.3%

North Run Capital, L P

0.29%

Springbok Capital Management, LLC

0.19%

Discover more

Frequently Asked Questions

What is SANARA MEDTECH INC share price today?

Can Indians buy SANARA MEDTECH INC shares?

How can I buy SANARA MEDTECH INC shares from India?

Can Fractional shares of SANARA MEDTECH INC be purchased?

What are the documents required to start investing in SANARA MEDTECH INC stocks?

What are today’s High and Low prices of SANARA MEDTECH INC?

What are today’s traded volumes of SANARA MEDTECH INC?

What is today’s market capitalisation of SANARA MEDTECH INC?

What is the 52 Week High and Low Range of SANARA MEDTECH INC?

How much percentage SANARA MEDTECH INC is down from its 52 Week High?

How much percentage SANARA MEDTECH INC is up from its 52 Week low?

What are the historical returns of SANARA MEDTECH INC?

Who is the Chief Executive Officer (CEO) of SANARA MEDTECH INC?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*